Lymphocytes Subpopulation in Cancer Patients
NCT02516371 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2015-08-26
Summary
This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.
Conditions
Interventions
- OTHER
-
lymphocyte
To evaluate the subpopulation of lymphocytes in cancer patients
Sponsors & Collaborators
-
DERSHENG SUN
lead OTHER
Principal Investigators
-
Yoon Ho Ko, MD, PhD · Uijeongbu St. Mary's Hospital, The Catholic University of Korea
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2016-06-30
- Completion
- 2018-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients
NCT02565589 ·Status: COMPLETED
-
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor
NCT04214717 ·Status: UNKNOWN ·Phase: NA
-
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
NCT02159937 ·Status: COMPLETED
-
Immune Repertoire of Ovarian HGSC
NCT03794115 ·Status: UNKNOWN
-
Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation
NCT01795378 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
NCT06029829 ·Status: UNKNOWN ·Phase: PHASE2
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Immuno-Oncology Database and Bioregistry
NCT04656873 ·Status: ACTIVE_NOT_RECRUITING
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
Deciphering Mechanisms Underlying Cancer Immunogenicity
NCT03958240 ·Status: RECRUITING ·Phase: NA
-
The Role of NK Cells to Detect Blood Infection in ALL.
NCT06160115 ·Status: NOT_YET_RECRUITING
-
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
NCT06626269 ·Status: RECRUITING ·Phase: NA
-
An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours.
NCT05133128 ·Status: TERMINATED ·Phase: NA
-
Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial
NCT06193733 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG
NCT03695757 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
NCT04948619 ·Status: RECRUITING ·Phase: PHASE2
-
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)
NCT04614051 ·Status: TERMINATED ·Phase: PHASE1
-
Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection
NCT00521287 ·Status: UNKNOWN ·Phase: PHASE2
-
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
NCT04960059 ·Status: COMPLETED
-
Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma
NCT00978913 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients
NCT04910295 ·Status: COMPLETED
-
Age-matched Reference Values for Circulating Natural Killer T-like Cells
NCT06450743 ·Status: COMPLETED ·Phase: NA
-
A Long Term Follow-up Study of TScan TCR-T Products
NCT06976736 ·Status: RECRUITING
-
The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression
NCT00854282 ·Status: UNKNOWN ·Phase: NA
-
Tumor-specific T Cells in Lung Cancer
NCT02515760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA